全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Case of Neurosarcoidosis with Labyrinthine Involvement

DOI: 10.1155/2014/530431

Full-Text   Cite this paper   Add to My Lib

Abstract:

Sarcoidosis is a chronic granulomatous disease of unknown aetiology, which may involve any organ system. It most commonly occurs in adults with childhood involvement being rare. Central nervous system involvement is seen in up to 25% and typically involves meningeal disease resulting in multiple cranial neuropathies. Other common clinical findings include seizures, headache, dementia, and pituitary dysfunction. Imaging plays a central role in the diagnosis with typical findings including pachymeningeal and leptomeningeal enhancing lesions. Other imaging findings include lacunar and major territory infarcts, hypothalamic and infundibular thickening, hydrocephalus, and cranial nerve enhancement. We present a case of an eight-year-old male patient with progressive headache, visual disturbance, unilateral sensory hearing loss, and multiple cranial neuropathies. Imaging findings demonstrated the classic pachymeningeal and leptomeningeal enhancement along much of the skull base, as well as enhancement of the right and left second and eighth cranial nerves. Extensive inflammatory changes were noted in the temporal bones and paranasal sinuses. There was also enhancement of the right and left labyrinths. Sinus biopsy confirmed sarcoidosis. We present the first case to our knowledge of sarcoid labyrinthitis. 1. Introduction Sarcoidosis is a chronic granulomatous disease of unknown aetiology with the presence of noncaseating granulomas [1]. It may involve any organ system, although the lungs and lymphatic system are among the more common sites. Sarcoidosis typically affects adults, with bimodal peaks in the third decade and sixth decade [1]. It is uncommon in childhood. There is an increased risk in people of African ethnicity [2], although this seems to be more prevalent in those living in northern climates. Isolated neurosarcoidosis is rare [3]. In postmortem series of patients with sarcoidosis, central nervous system involvement is seen in 14–25% [4–7]. Symptomatic cases are however reported with a much lower frequency (3%–5%) [8, 9]. This suggests that CNS involvement is more common than clinically apparent. Depending on the organ systems involved, clinical findings may vary widely. With central nervous system involvement, symptoms include those of cranial neuropathy, particularly the facial nerve and the optic nerve. Other symptoms include seizures, headache, dementia, weakness, parasthesia, and pituitary/hypothalamic dysfunction [10]. 2. Case Report We present a case of an eight-year-old male with a progressive history of headache, neck pain, and

References

[1]  Statement on Sarcoidosis, “Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS board of directors and by the ERS Executive Committee February 1999,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 736–755, 1999.
[2]  B. A. Rybicki, M. Major, J. Popovich Jr., M. J. Maliarik, and M. C. Iannuzzi, “Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization,” American Journal of Epidemiology, vol. 145, no. 3, pp. 234–241, 1997.
[3]  D. A. Nowak and D. C. Widenka, “Neurosarcoidosis: a review of its intracranial manifestation,” Journal of Neurology, vol. 248, no. 5, pp. 363–372, 2001.
[4]  D. Pickuth, R. P. Spielmann, and S. H. Heywang-Kobrunner, “Role of radiology in the diagnosis of neurosarcoidosis,” European Radiology, vol. 10, no. 6, pp. 941–944, 2000.
[5]  L. E. Siltzbach, D. G. James, E. Neville, et al., “Course and prognosis of sarcoidosis around the world,” The American Journal of Medicine, vol. 57, no. 6, pp. 847–852, 1974.
[6]  B. J. Stern, A. Krumholz, C. Johns, P. Scott, and J. Nissim, “Sarcoidosis and its neurological manifestations,” Archives of Neurology, vol. 42, no. 9, pp. 909–917, 1985.
[7]  B. J. Stern, A. Krumholz, and C. J. Johns, “Neurosarcoidosis: presentation and management,” Annals of the New York Academy of Sciences, vol. 465, pp. 722–730, 1986.
[8]  F. J. Lexa and R. I. Grossman, “MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy,” American Journal of Neuroradiology, vol. 15, no. 5, pp. 973–982, 1994.
[9]  J. K. Smith, M. G. Matheus, and M. Castillo, “Imaging manifestations of neurosarcoidosis,” American Journal of Roentgenology, vol. 182, no. 2, pp. 289–295, 2004.
[10]  R. Shah, G. H. Roberson, and J. K. Cure, “Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis,” American Journal of Neuroradiology, vol. 30, no. 5, pp. 953–961, 2009.
[11]  G. A. Christoforidis, E. M. Spicklcr, M. V. Recio, and B. M. Mehta, “MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment,” American Journal of Neuroradiology, vol. 20, no. 4, pp. 655–669, 1999.
[12]  S. Seltzer, A. S. Mark, and S. W. Atlas, “CNS sarcoidosis: evaluation with contrast-enhanced MR imaging,” American Journal of Neuroradiology, vol. 12, no. 6, pp. 1227–1233, 1991.
[13]  J. P. Zajicek, N. J. Scolding, O. Foster et al., “Central nervous system sarcoidosis—diagnosis and management,” Monthly Journal of the Association of Physicians, vol. 92, no. 2, pp. 103–117, 1999.
[14]  J.-L. Dumas, D. Valeyre, C. Chapelon-Abric et al., “Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy,” Radiology, vol. 214, no. 2, pp. 411–420, 2000.
[15]  I. B. Colvin, “Audiovestibular manifestations of sarcoidosis: a review of the literature,” The Laryngoscope, vol. 116, no. 1, pp. 75–82, 2006.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413